Needham & Company Upgrades Zimmer Biomet (ZBH) to Strong Buy; Supply Issues Only Temporary
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Zimmer Biomet Holdings (ZBH): Sales Miss Was Disappointing But Now Its In The Stock - Leerink
November 1, 2016 7:05 AM EDTLeerink Partners analyst, Richard Newitter, reiterated his Outperform rating on shares of Zimmer Biomet (NYSE: ZBH) but cut the price target to $136 from $150.
The analyst thinks ZBHs 3Q sales miss was disappointing but considering the 14% pullback, with ZBH... More
Jefferies Cuts Price Target on Zimmer Biomet Holdings (ZBH) to $129 Following 3Q Miss
November 1, 2016 7:04 AM EDTJefferies maintained a Buy rating on Zimmer Biomet Holdings (NYSE: ZBH), and cut the price target to $129.00 (from $150.00), following the company's 3Q earnings report. a $10mn miss was attributed to unforeseen supply chain issues. Revenue guidance was lowered by $58mn, as EPS was cut... More
Zimmer Biomet Holdings (ZBH) Reports In-Line Q3 EPS
October 31, 2016 7:30 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.79, in-line with the analyst estimate of $1.79. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.84 billion.
The Company updated its full-year 2016 constant currency revenue and adjusted earnings per share guidance. The Company now estimates full-year... More

